‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumours.
CRISPR cancer trial success paves the way for personalized treatments
Posted in biotech/medical
Posted in biotech/medical
‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumours.